Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Neoadjuvant Treatment and Molecular Characterization of Locally Advanced Breast Cancer

Trial Profile

Neoadjuvant Treatment and Molecular Characterization of Locally Advanced Breast Cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Mar 2017

At a glance

  • Drugs Docetaxel (Primary) ; Trastuzumab (Primary) ; Carboplatin
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Jun 2014 Trial status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 03 Aug 2012 Planned end date changed from 1 May 2012 to 1 May 2013 as reported by ClinicalTrials.gov.
    • 14 Jun 2010 Primary endpoint results published in Cancer
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top